← Leaderboards
Thomas Calvin Abshire
Versiti Wisconsin, Inc.
$2,038,181
Attributed
$4,076,361
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $840.9K · FY2013–18$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$4,076,361 · 1
By mechanism
R01$4,076,361 · 1
Top collaborators
- Robert R Montgomery5 shared
Most similar at Versiti Wisconsin, Inc.
Same institution · by research overlap
- Christian Kastrup$2,909,910
- James O'Donnell$2,925,819
Others in their field
Top investigators on “Disease Phenotype”
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$186,551,214
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- David M Nathan · Massachusetts Institute Of Technology$140,596,299
- James E. Gern · University Of Wisconsin-Madison$139,483,313
- John M Lachin · George Washington University$136,050,105
Research focus
Disease PhenotypeEnrollmentDiagnosticBaseDiagnostic TestsDisease DiagnosisBlinded19p13CanadaChildChildhoodAdultClinic VisitsCohortComparativeComparative EffectivenessAffectCompare EffectivenessCorrelation StudiesCost EffectivenessDdavpDentalDiagnosisF8 Gene
Grant awards (5)
Comparative Effectiveness in the Diagnosis of VWD$807,300
R01 · FY2018 · HL
Comparative Effectiveness in the Diagnosis of VWD$817,579
R01 · FY2017 · HL
Comparative Effectiveness in the Diagnosis of VWD$829,339
R01 · FY2016 · HL
Comparative Effectiveness in the Diagnosis of VWD$840,880
R01 · FY2015 · HL
Comparative Effectiveness in the Diagnosis of VWD$781,263
R01 · FY2013 · HL